semaglutide and heart failure In patients with cardiometabolic #HFpEF, #semaglutide #tirzepatide reduced the risk of hospitalization for or all-cause mortality vs sitagliptin, but tirzepatide offered no additional benefit over semaglutide. https://ja.ma/3JO2SQc Semaglutide may help treat heart
Description
President Trump recently announced a deal with drugmakers to expand access to GLP-1 drugs to Medicare patients starting in 2026
Compare prescription GLP-1 medications vs compounded weight loss injections
GLP-1RAs reduce events linked to atherogenic cardiovascular disease (especially ischemic stroke) and also renal outcomes (FLOW trial with semaglutide), with a limited effect on heart failure
Built with liposomal R3HBG ketone, 5-HTP, and prebiotic fibe
Our 3-tier stacking approach sequences peptides by goal recovery, fat loss, longevity without overloading the body.
